Occurrence of Anxiety and Depression among Stable COPD Patients and its Impact on Functional Capability (original) (raw)
Related papers
PREVALENCE OF ANXIETY AND DEPRESSION IN STABLE PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
National Journal of Medical Research, 2021
Introduction: To study the prevalence of anxiety and depression in stable COPD patients. Methodology: 100patients of stable COPD were assessed to look for the presence of anxiety and depression using beck anxiety inventory (BAI) and patient health questionnaire (PHQ-9). Patients already on treatment forpsychiatric illnesses were excluded from the study. Patients with total score above cut off value (BAI >7 ORPHQ-9 >4), were assessed in the psychiatry department. Quantitative data was compiled and statistical analysis was done. Results: Among study population 68% were males, 62% were in the age group of 60-80years, 83 % were ex smokers and 92 % of them were exposed to indoor air pollution (chullahs). It was found that 64 % of the study population had psychiatric morbidity out of which 42% had mixed anxiety and depressive symptoms. Psychiatric symptoms were more prevalent in female patients (97%, P value is0.003), and in patients who had more severe disease (P value is 0.04), 6 minute walk distance < 300 m (P value is 0.00001), percentage of desaturatoin> 3% after 6 M.W (P value is 0.0001) and Smoking Index >400.Smoking status and 6 minute walk distance were independently associated with the development of anxiety and depression with significant P values in stable COPD patients. Conclusion: Anxiety and depression are common psychiatric co-morbidities associated with COPD patients. Early diagnosis and proper management of COPD and timely evaluation for psychiatric illnesses is essential for the better outcomes in COPD patients.
International journal of scientific research, 2019
Background: The aim of the study was to find the prevalence of anxiety and depression in COPD patients as undiagnosed cases may have an negative impact on the overall health status and find its correlation with factors like age, gender, disease severity and health related Quality of Life (QOL). Method: 226 subjects enrolled in this study. Basic demographic details were gathered. Hospital Anxiety and Depression Scale (HADS) was used to assess anxiety and depression. QOL was assessed using St. George's Respiratory Questionnaire (SGRQ). Result: Prevalence of anxiety and depression in COPD subjects in the study was 35.4% and 52.7% as per HADS questionnaire. Age and SGRQ score showed a significant positive correlation whereas disease severity showed a significant negative correlation with anxiety and depression. Association of the anxiety and depression with gender showed anxiety to be statistically significant in males and females. Conclusion: Higher rates of depression and anxiety symptoms are seen in patients with COPD even in earlier stages of the disease.
Symptoms of anxiety and depression in patients with chronic obstructive pulmonary disease
Despite the prevalence and importance of anxiety and depressive symptoms in chronic obstructive pulmonary disease (COPD) patients, procedures for routine screening in therapeutic protocols are not commonly used. to assess the symptoms of anxiety and depression in COPD patients and to evaluate their relation to patients' demographic parameters and clinical characteristics. The research included 40 COPD patients, treated at the Institute of Lung Diseases and Tuberculosis, Clinical Centre Serbia in Belgrade, from November 2010 to February 2011. Study data were assessed by the questionnaire designed for the purposes of the present study together with Hamilton Anxiety Rating Scale (HARS) and Hamilton Depression Rating Scale (HDRS). Mean HARS score was 10.7 (SD=6.5) (22.5% subjects scored > or = 17) and mean HDRS score was 10.7 (SD=8.2) (20.0% subjects scored > or = 17). Depression was significantly higher in women (Z=-1.971: p=0.049). Lower value of forced expiratory volume in ...
International Journal of Advanced and Integrated Medical Sciences
Introduction Chronic disease like chronic obstructive pulmonary disease (COPD) is associated with various comorbidities. Anxiety and depression are among the common comorbidities and have significant impact on socioeconomic status of the person as well as the course of disease. In our study, we screened COPD patients attending the outpatient department (OPD) of pulmonary medicine for anxiety and depression, using different scales that include questionnaires. About 46.2 and 34.6% cases were found to have depression and anxiety respectively, among all COPD patients (n = 156). Incidence of anxiety and depression was directly proportional to severity of disease. Age, gender, locality, educational, marital, and socioeconomic statuses are some factors that play important roles in the development of these psychiatric comorbidities. Hence, mental assessment of COPD patients should be mandatory with every visit to the OPD. How to cite this article Jaiswal A, Kumar A, Rathi H, Sharma CS, Shar...
Anxiety and depression-Important psychological comorbidities of COPD
Journal of thoracic disease, 2014
Anxiety and depression are common and important comorbidities in patients with chronic obstructive pulmonary disease (COPD). The pathophysiology of these psychological comorbidities in COPD is complex and possibly explained by common risk factors, response to symptomatology and biochemical alterations. The presence of anxiety and/or depression in COPD patients is associated with increased mortality, exacerbation rates, length of hospital stay, and decreased quality of life and functional status. There is currently no consensus on the most appropriate approach to screening for anxiety and depression in COPD. Treatment options include psychological [relaxation, cognitive behavioural therapy (CBT), self-management] and pharmacological interventions. Although there is some evidence to support these treatments in COPD, the data are limited and mainly comprised by small studies. Pulmonary rehabilitation improves anxiety and depression, and conversely these conditions impact rehabilitation...
Depression and anxiety in patients with COPD
Under-recognised and untreated depression and anxiety symptoms have deleterious effects on physical functioning and social interaction increasing fatigue and healthcare utilisation in patients with chronic obstructive pulmonary disease (COPD). Depression and anxiety are challenging to identify and treat because their symptoms often overlap with those of COPD. The cause(s) of depression and anxiety symptoms are multifactorial and include behavioural, social and biological factors. Less than one-third of COPD patients with comorbid depression or anxiety symptoms are receiving appropriate treatment. Factors that contribute to the lack of provision of treatment are varied, they include patient perceived barriers, for example lack of knowledge and reluctance to receive antidepressant drug therapy; poor treatment compliance and lack of a standardised diagnostic approach; and scarcity of adequate resources for mental health treatment.
Depression and Anxiety in cases of COPD
IP Innovative Publication Pvt. Ltd, 2017
Patients with chronic obstructive pulmonary disease (COPD) have many times under-recognized and untreated depression and anxiety symptoms which lead to harmful effects on physical functioning and social interaction. Depression and anxiety are often difficult to identify in patients of COPD. The causes for these associated diseases in COPD are multifactorial including social, behavioural and biological factors. Less than 35% of COPD patients with these co-morbid diseases are receiving appropriate treatment. The factor for this low treatment rate includes patients perceived barrier e.g. reluctance to receive antidepressant drug therapy, poor treatment compliance and deficiency of standardized diagnostic approach. There are inconclusive evidence to support the efficacy of anti-depressant drug therapy in patients of COPD with comorbid depression and anxiety. Promising results are being noticed in pulmonary rehabilitation, psychological therapy and the collaborative care model in reducing depression and anxiety symptoms in patients with COPD. But, the main limitations are short term follow up period. More research is required to establish the efficacy of these interventions in randomized control trial with larger samples and longer follow up periods.
Anxiety and depression in chronic obstructive pulmonary disease: A new intervention and case report
Cognitive and Behavioral Practice, 2005
Anxzety and depmsston coexist frequently zn chronzc obstructwe pulmona~:y dzsease and compound the tmpact of the dzsease on quality of bfe and functzonal status Howev~ httle attentzon has been gwen to the development of treatment strategtes for thzs subset of patzents. The current artzcle describes the development of a new, mult~component cognztzve behavzoral treatment for reduczng anxzety and depresswn among patzents wtth respiratory dzsease (CBT-RADAR). Outcome data from a group of 5 patzents who partzczpated zn an ongoing clzn~cdl thai are revzewed to dlu~trate the strengths and hmztatlons of thzs mterventwn C HRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) is a serious and progressive medical illness with a profound impact on life function, economic burden, and mortality. Physical symptoms include shortness of breath, chest pain, cough, weakness, fatigue, poor exercise tolerance, nutritional abnormalities, and damage to the heart and brain. The disease affects 14 to 20 million people and is the fourth leading cause of death in the United States (Centers for Disease Control, 2003). Hospital readmission occurs frequently, and general rates of service use are high (Centers for Disease Control, 2005). Associated economic costs are estimated at $24 billion per year (Sullivan, Ramsey, & Lee, 2000). Quality of life and functional status are severely impaired as a result of both the physical symptoms and limitations of COPD and frequently coexistent psychological difficulties. Coexistent anxiety and depression are particularly common in COPD (Borson, Claypoole, & McDonald, 1998, Brenes, 2003). In many cases, the symptoms of COPD overlap with those of anxiety or depression (e.g., sleep disturbance, decreased energy, shortness of breath, and catastrophic thoughts about physical symptoms) and differential diagnosis is difficult. Nevertheless, anxiety and depressive diagnoses have been established via chnical interview in 16% to 34% of patients with COPD
Depression, Anxiety and Stress among COPD Patients: A Comparative Cross Sectional Study
2020
Background: Chronic Obstructive Pulmonary Disease (COPD) is associated with depression, anxiety and stress, which are the commonest disorders resulting in significant morbidity and mortality. There is paucity of information regarding the association between depression, anxiety, and stress and chronic obstructive pulmonary disease in the present setup. This comparative cross-sectional study was designed to determine the magnitude of Depression, Anxiety and Stress and associated factors among COPD patients. Methods: Sixty five COPD patients and equal number of age and sex matched healthy individuals were included in the study. The study was conducted at Jimma University Specialized Hospital JUSH), from March 01 to April 30/2016. Spirometric assessment was done to evaluate severity of COPD. Depression, anxiety and stress scale (DASS 21) was used for the assessment of severity of depression, anxiety and stress. Chi-square test, independent t-test, Fisher’s exact test, one way ANOVA and ...
Factors affecting health status in COPD patients with co-morbid anxiety or depression
International journal of chronic obstructive pulmonary disease, 2007
Health status questionnaires provide standardized measures of patients' perceptions of the impact of disease on their daily life and well-being. Factors associated with health status were examined in a sample of 58 outpatients with chronic obstructive pulmonary disease (COPD) and co-morbid anxiety and/or depression. A cross-sectional descriptive study was conducted with the following measures: The St. George's Respiratory Questionnaire (SGRQ); the Beck Anxiety Inventory (BAI); the Beck Depression Inventory, 2nd edition (BDI); the Pittsburgh Sleep Quality Index (PSQI); and spirometry. Disease severity as measured with spirometrywas not related to health status. Perceptions of poor health as implied by the health status scores were positively associated with symptoms of anxiety and depression, sleep disturbances, and level of daily functioning. There were statistically significant differences between men and women on COPD severity, age, and the BAI scores. The findings emphasi...